|
|
|
|
Phases and Time of Medical Devices SFDA Registration
|
| |
The whole registration process of a MD product contains four phases:
1) To prepare the technical materials and draft product technical standard;
2) To conduct clinical trial or verification;
3) To conduct type test;
4) To inspect, technical evaluate the completely set materials for product
registration and then approve the application.
The reference time of them is:
1) Phase 1: Preparation of technical materials as well as standard written
is entirely operated by the applicant of product registration (such as
domestic and foreign manufacturers) and its authorized registration agent.
Therefore, the cycle length depends entirely on the exchange and
communication between the two sides.
2) Phase 2: The time of clinical trials with high techniques and complex
operations depends more entirely on the applicants of product registration.
Based on experience, it normally takes at lest 3 calendar months for
domestic products and no less than 6 calendar months for foreign products.
3) Phase 3: The type test for product registration is conducted by MD
testing institutions accredited by SFDA. About the time, it is not clearly
defined. However, it usually takes at least 3 calendar months based on
experience.
4) Phase 4: Chinese regulatory authorities spend within 30 working days for
Class I, 60 working days for Class II and 90 working days for Class III
respectively, in deciding if the product can be registered in China. For
foreign products, it is 90 working days generally. Moreover, in the course
of review of registration applications, the time for testing, expert review
and hearing does not count within the period specified above. However, the
corresponding authority for technical evaluation spends no more than 45
working days for review after receiving the itegrate supplemented materials
required.
Therefore, based on product classification, domestic or foreign, IVD reagent
or not, placing into market or not, the whole cycle is different absolutely.
A good example is the more advanced new products. Once the risk and
effectiveness of this product is difficult to determine, the technical
evaluation authority authorized by SFDA can organize experts to review and
hearings. The corresponding time does not count within the time limit. Thus,
it is impossible to clarify the specific cycle length.
|
| |
| |
|
|
:
Site Search
+86-755-2583-1330
